| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/18/2006 | WO2006007853A3 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 05/18/2006 | WO2005123962A3 Gene targeting in eukaryotic cells by group II intron ribonucleoprotein particles |
| 05/18/2006 | WO2005118640A3 A h+-gated ion channel |
| 05/18/2006 | WO2005117577A3 Model for neurodegenerative disorders |
| 05/18/2006 | WO2005089268A3 Compositions and methods for optimizing cleavage of rna by rnase h |
| 05/18/2006 | WO2005087806A3 Cd38 splice variant and uses thereof |
| 05/18/2006 | WO2005077117A3 Transgenic corn seed with enhanced amino acid content |
| 05/18/2006 | WO2005067491A3 Toxin complex proteins and genes from xenorhabdus bovienii |
| 05/18/2006 | WO2005054494A3 Sequence-specific inhibition of small rna function |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | WO2005019422A3 Silencing of tgf-beta receptor type ii expression by sirna |
| 05/18/2006 | WO2005012497A3 Translocation tagging |
| 05/18/2006 | WO2005012407A3 Polymer encapsulation of adenoviruses |
| 05/18/2006 | WO2005007623A3 Inhibition of syk kinase expression |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2004058939A3 TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs |
| 05/18/2006 | WO2004014306A3 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 05/18/2006 | WO2003106616A3 MEMBRANE-ANCHORED ß2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES |
| 05/18/2006 | WO2002096356A3 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR |
| 05/18/2006 | US20060107427 Hybrid maize plant and seed 31D58 |
| 05/18/2006 | US20060107426 Inbred corn line PHEBA |
| 05/18/2006 | US20060107425 Hybrid maize plant and seed 39A94 |
| 05/18/2006 | US20060107424 Hybrid maize plant and seed 31P41 |
| 05/18/2006 | US20060107422 Inbred corn line PHDRW |
| 05/18/2006 | US20060107353 Plant bioreactors |
| 05/18/2006 | US20060107352 Transgenic expression cassettes for expression of nucleic acids in the plant blooms |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060107350 Fatty acid elongases |
| 05/18/2006 | US20060107349 isolated nucleic acid sequence that activates wax biosynthesis operably linked to a heterologous promoter; drought resistant plant |
| 05/18/2006 | US20060107348 High yielding soybean plants with low linolenic acid |
| 05/18/2006 | US20060107347 Maize Cr1Bio gene promoter and its use to direct root-preferred transgene expression in plants |
| 05/18/2006 | US20060107346 Vector construct of a nitrogen responsive promoter that directs transcription, and a second nucleic acid molecule having to be transcribed; first and second nucleic acid molecules are heterologous to each other |
| 05/18/2006 | US20060107345 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 05/18/2006 | US20060107344 Organ preferential genes identified by T-DNA insertional mutagenesis of rice |
| 05/18/2006 | US20060107343 Plant cells and plant bodies with modified cell growth, development and differentiation |
| 05/18/2006 | US20060107342 Expressing within the plant a cystathionine gamma -synthase encoded by a polynucleotide mutated in, or lacking, a region encoding an N-terminal portion of cystathionine gamma -synthase, region being functional in downregulating an activity of cystathionine gamma -synthase in the plant |
| 05/18/2006 | US20060107341 An isolated nucleotide sequence encoding a regulatory fusion protein consisting of modified ligand-binding domain of a human estrogen receptor and a transcription blocking domain comprising a mutated restriction enzyme capable of binding but not cleaving DNA |
| 05/18/2006 | US20060107340 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto |
| 05/18/2006 | US20060107339 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 05/18/2006 | US20060107337 Elimination of endogenous porcine retrovirus |
| 05/18/2006 | US20060106208 Process and equipment for plasmid purfication |
| 05/18/2006 | US20060106207 3-phosphoglycerate dehydrogenase having a reduced feedback inhibition by L-serine; produced by deleting at least 79 amino acids at the C terminus of the wild-type serA sequence |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060106196 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination |
| 05/18/2006 | US20060106120 Method of degrading plastic and process for producing useful substance using the same |
| 05/18/2006 | US20060105983 Cytotoxic agents |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105980 ARC186 aptamer PEG conjugate; transplant rejection; cardiovascular disorders; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105975 Nucleic acid conjugate comprising delivery aptamer connected to oligonucleotide; delivery aptamer may be connected directly to oligonucleotide, or may be connected indirectly to oligonucleotide, such as through a linker; oligonucleotide may be therapeutic, diagnostic or imaging oligonucleotide |
| 05/18/2006 | US20060105974 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 05/18/2006 | US20060105973 nucleosides, phosphorothioate linkages; colloids; osteoporosis; depression; metabolic disorders such as obesity, diabetes, atherosclerosis and hyperlipidemia |
| 05/18/2006 | US20060105949 Pharmaceutical preparations and methods for inhibiting tumors |
| 05/18/2006 | US20060105914 Plant wall degradative compounds and systems |
| 05/18/2006 | US20060105468 saturating frozen biological tissues in a soak solution that comprising dimethyl sulfoxide and water miscible solvents, then extracting macromolecules from the tissues |
| 05/18/2006 | US20060105459 Transgenic mice containing NTTP1 phosphatase gene disruptions |
| 05/18/2006 | US20060105458 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression |
| 05/18/2006 | US20060105451 Genetically engineered P30 antigen improved antigen cocktail, and uses thereof |
| 05/18/2006 | US20060105446 Biodegradable, resistant to nitrate salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 05/18/2006 | US20060105442 Promoters and proteins from Clostridium thermocellum and uses thereof |
| 05/18/2006 | US20060105436 Immunosuppressant selected from prolyl-rapamycin, 4-hydroxy-prolyl-rapamycin, 4-hydroxyprolyl-26-demethoxy-rapamycin, 3-hydroxy-prolyl-rapamycin, 3-hydroxy-prolyl-26-demethoxy-rapamycin, and trans-3-aza-bicyclo[3,1,0]hexane-2-carboxylic acid rapamycin |
| 05/18/2006 | US20060105432 Method for the production of vitamin b12 |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105428 Alkaline protease |
| 05/18/2006 | US20060105425 Aspergillus niger promoter for expressing genes in host cells |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105417 Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105385 Xenobiotic related induction of gene expression |
| 05/18/2006 | US20060105383 Biopolymer detecting method and biochip |
| 05/18/2006 | US20060105381 Polymorphisms of the OCTN1 cation transporters associated with inflammatory bowel disorders |
| 05/18/2006 | US20060105380 Synthesizing cDNA via primers, mixing with second sample, transcribing, then detecting |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105377 Screening to optimize RNAi |
| 05/18/2006 | US20060105376 Novel full-length cDNA |
| 05/18/2006 | US20060105374 RhoB variants and methods of use |
| 05/18/2006 | US20060105371 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 05/18/2006 | US20060105363 Methods for determining transcriptional activity |
| 05/18/2006 | US20060105362 Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms |
| 05/18/2006 | US20060105361 Donor yeast strain for transfer of genetic material |
| 05/18/2006 | US20060105358 Generating genetic engineered double-stranded DNA; providing templates, incubating , extending primers, hybridization, producing DNA product molecules that may be easily and directly ligated to recipient molecules; need not be cleaved with restriction enzymes; amplification; iterative DNA synthesis |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105344 Modulation of deubiquitinase family members |
| 05/18/2006 | US20060105341 Trap-tagging: a novel method for the identification and purification of rna-protein complexes |
| 05/18/2006 | US20060105340 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 05/18/2006 | US20060105337 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 05/18/2006 | US20060105336 autologous T cell vaccines; multiple sclerosis |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105326 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
| 05/18/2006 | US20060105323 Multi-reporter gene model for toxicological screening |
| 05/18/2006 | US20060105318 Compositions and Methods for Non-targeted Activation of Endogenous Genes |
| 05/18/2006 | US20060105052 Cationic nanoparticle having an inorganic core |
| 05/18/2006 | US20060105006 Use of metalloprotease inhibitors to induce and/or stimulate the growth of head hair or other hairs and/or to slow down their loss |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104989 Essential novel bacterial polypeptides |